Q: What is the FDA HALO AI data platform and what does it do? A: The FDA HALO AI data platform is a unified data backbone that aggregates records from more than 40 FDA systems to bring submissions, reviews, and operational data into one place. It allows staff to query documents, build workflows, and avoid manually uploading the same files for each chat. Q: How does the FDA HALO AI data platform speed up FOIA processing? A: By centralizing request intake and indexing, classifying topics to identify likely custodians, searching across centers for responsive records, and flagging sensitive data for AI-assisted redaction with human review, the FDA HALO AI data platform reduces back-and-forth and speeds record retrieval. Officials report about an 85% gain in FOIA processing efficiency compared with manual methods. Q: What security measures protect data within the FDA HALO AI data platform? A: Officials said the platform enforces the highest level of security with data compartmentalized and segmented by center. Role-based access controls and audit trails are used to protect sensitive information, including trade secrets and personal data. Q: How does the HALO platform work with Elsa 4.0 and why is that integration important? A: The FDA HALO AI data platform is integrated with Elsa 4.0 so staff can ask questions across consolidated sources, trigger workflows, and keep context without re-uploading documents for each chat. That linkage reduces duplicate document handling and preserves context across queries. Q: What measurable improvements has the FDA reported since deploying HALO for FOIA requests? A: Agency officials reported about an 85% improvement in FOIA processing efficiency compared with manual processes. They also noted the platform addresses roughly 12,000 annual FOIA requests that are increasing about 20% per year. Q: Can inspectors use the FDA HALO AI data platform during on-site inspections? A: Officials said HALO is not yet used as a live tool during on-site inspections because it would be difficult for an inspector to integrate the information during an inspection. They added the platform can inform inspection planning and help detect anomalous patterns before or after inspections. Q: How does the FDA HALO AI data platform help detect risks like economically motivated adulteration? A: By aggregating import and submission data across centers, the FDA HALO AI data platform helps spot anomalous patterns that can indicate fraud or economically motivated adulteration. FDA leaders said these risk signals support smarter targeting and faster interventions. Q: What benefits does the FDA HALO AI data platform offer to the public and industry? A: The platform enables faster transparency through quicker FOIA turnarounds, better consistency from centralized data and tracked workflows, and smarter oversight via improved risk detection and clearer summaries. Officials also said it reduces duplicate uploads and strengthens protections around sensitive data.